Tagged with clinical research

CRO The general manager of one of the leading CROs in Romania explains how the country in gathering pace as a top tier clinical trials destination country within the region and how the priority is now about on-time project delivery. Could you please start by introducing PSI and its engagement with…

clinical research The head of Management Center for the North West Africa of a large multinational speaks out about the defining characteristics of the Algerian pharmaceutical market and discusses the importance of training local medical practitioners in clinical research techniques and methodologies. Now, you are the Head of the Management Center for…

clinical research Clinical research and access are the name of the game. The Executive Director of the association bringing together the most important research-based pharmaceutical companies discusses how the association has stepped up to partner up with the government and stakeholders to fight for the same objective and create a better health…

clinical research Liz Chatwin came to Korea as general manager of AstraZeneca in the fall of 2013, following a period working at the company’s Chinese affiliate for several years. She contrasts the two markets and highlights the unprecedented quality of Korea’s clinical research capacity. What were your initial impressions of the market…

clinical research The general director of the National Institute for Psychiatry discusses the Institute’s commitment to translating clinical research into better care for patients, the social stigma patients with mental disorders still face in Mexico and the increasing importance of mental health on productivity and the country’s economic development. You have been…

Parexel Pilar Rivas, associate director of global contract research organization Parexel’s Spanish affiliate, discusses cultural differences across Spain and their impact on clinical trials, as well as the world-class infrastructure that allows CROs in Spain to perform high-quality research.   Do you feel that supporting clinical research is a priority for the…

CRO Alan Ong, executive vice president for the Asia/Pacific region at INC Research, outlines the key challenges and opportunities that CROs face in the Malaysian clinical trial segment and describes INC’s role in raising the country’s profile as a destination for research.   You represented another global CRO for almost 13…

clinical research Clinical Research Malaysia’s CEO discusses the need for Malaysia to focus on high quality pivotal trials rather than simply on a high number of trials. He shares with us the encouraging progress of Malaysia as an attractive place for trials since clinical research was placed under the healthcare NKEA National…

Choice Pharma Full service CRO Choice Pharma moved its operations from Europe to Asia in 2008, and since then the company has thrived. The managing director and business director for the company discuss the merits of Taiwan for CROs, and how the environment is better today in Asia than in Europe for…

clinical research Industry veteran and CEO of JSS Medical research explains what he thinks is going wrong with clinical research in Canada today, how Canadian CROs are losing out at the hands of global CROs, and offers some advice on how to stay in the game. What are the biggest challenges facing…

Infinite Clinical Research We understand that Mexico has a lot of advantages for holding clinical trials, including the large population, access to specialized patient populations, higher patient retention rates and cheaper costs by up to 30% when compared to the United States and Europe. In your opinion, what is the most common reason…

Medicilon/MPI Preclinical Research Shanghai You completed your higher education in the US and worked there for a period afterwards; what caused you to move back to China and start this company? A lot of people are now returning to China after gaining extensive experience in the US. I personally enjoyed the vast experience that…